ijms-logo

Journal Browser

Journal Browser

The Endothelial Glycocalyx: Physiological, Pathological and Therapeutic “Holy Grail”

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 29 June 2024 | Viewed by 92

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, University of Adelaide, Adelaide 5371, Australia
Interests: nitric oxide signalling; heart disease in women; cardiotoxicity/cardioprotection
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Since the first reports of the pioneering experiments of Furchgott and Zawadzki in 1980, followed by Moncada et al.’s critical observations that atherogenesis within large arteries produces similar changes in vascular reactivity to those of endothelial denudation, the concept of “endothelial dysfunction” has been used widely, usually to describe the impairment of vasodilator responses to nitric oxide (NO)-releasing agents.

Much has changed since then. It has become increasingly clear that changes in the arterioles in terms of their vascular physiology may be far more important than those in large arteries, and that these disturbances of homeostasis may be pivotal to the pathophysiology of vascular ageing, myocardial ischaemia, heart failure, COVID vasculitis and other disorders. Furthermore, the overall control of disordered microvascular function may reside primarily in the functional integrity of the endothelial glycocalyx, a carbohydrate-rich layer that lies between the endothelium and the vascular lumen, modulating microvascular permeability, rheology, platelet activation and, finally, autacoidal function (and, therefore, fluctuations in microvascular tone).

This Special Issue represents an opportunity to update readers on all aspects of this seminal area of progress. To achieve this objective, we seek articles addressing the entire spectrum of this new view of vascular (patho)physiology and its therapeutic implications.

Prof. Dr. John D. Horowitz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atherogenesis
  • endothelial dysfunction
  • disordered microvascular function
  • glycocalyx
  • vascular

Published Papers

This special issue is now open for submission.
Back to TopTop